Trump Taps Former GlaxoSmithKline Vaccine Chief to Lead COVID-19 Vaccine Development
U.S. President Donald Trump has appointed Moroccan expert Moncef Slaoui, former head of GlaxoSmithKline Plc’s vaccine division, to co-lead the operation to develop a vaccine against the new coronavirus with Gustave Perna, a U.S. general.
According to the U.S. agency Bloomberg, Dr. Moncef Slaoui, 60, will voluntarily oversee this initiative known as Operation Warp Speed.
Thanks to this Trump administration project, 300 million doses of the COVID-19 vaccine will be available by the end of the year.
According to the biotechnology expert, the clinical study began on March 25. "So we are testing this vaccine. We will be sure of its protective potential in the coming months. By the end of the year, probably, we will know if it works and we can produce it," he added.
Related Articles
-
Moroccan Official Reassigned After Assault; Attacker Sentenced to Prison
19 April 2025
-
Ryanair’s Abrupt Cancellation of Malaga-Nador Route Sparks Outrage Among Moroccan Expats
19 April 2025
-
Moroccan Court Orders Repayment as Swiss Entrepreneur’s Textile Firm Faces Bankruptcy
19 April 2025
-
Moroccan Officials Under Investigation for Undeclared Foreign Assets and Bitcoin Trafficking
19 April 2025
-
Moroccan Real Estate Developers Accused of Tax Evasion Scheme in Jorf El Melha
19 April 2025